X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2534) 2534
Book Review (607) 607
Magazine Article (251) 251
Publication (133) 133
Book Chapter (22) 22
Trade Publication Article (19) 19
Conference Proceeding (15) 15
Book / eBook (10) 10
Government Document (9) 9
Newsletter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1970) 1970
humans (1799) 1799
ophthalmology (1346) 1346
female (1071) 1071
male (992) 992
dry eye (917) 917
dry eye syndromes - drug therapy (917) 917
middle aged (779) 779
adult (650) 650
eye diseases (590) 590
aged (541) 541
dry eye syndromes (537) 537
care and treatment (433) 433
animals (425) 425
treatment outcome (375) 375
ocular surface (359) 359
disease (349) 349
ophthalmic solutions (320) 320
dry eye syndromes - diagnosis (319) 319
keratoconjunctivitis sicca (314) 314
dry eye disease (296) 296
cornea (285) 285
inflammation (283) 283
dry eye syndromes - metabolism (278) 278
dry eye syndromes - etiology (272) 272
prevalence (263) 263
prospective studies (263) 263
ophthalmic solutions - administration & dosage (259) 259
sense organs (251) 251
diagnosis (249) 249
research (249) 249
dry eye syndromes - physiopathology (246) 246
drug therapy (237) 237
tears - metabolism (222) 222
dry eye syndrome (220) 220
aged, 80 and over (217) 217
ophthalmic solutions - therapeutic use (217) 217
health aspects (213) 213
administration, topical (211) 211
pharmacology & pharmacy (210) 210
ophthalmic drugs (206) 206
sjogrens-syndrome (201) 201
analysis (200) 200
eye (199) 199
dry eye syndromes - therapy (180) 180
tear film (180) 180
surveys and questionnaires (176) 176
symptoms (176) 176
dry eye syndromes - pathology (175) 175
genetic structures (175) 175
disease models, animal (173) 173
risk factors (173) 173
efficacy (172) 172
young adult (172) 172
double-blind method (166) 166
tears - chemistry (166) 166
patients (160) 160
tears (154) 154
cyclosporine (152) 152
meibomian gland dysfunction (152) 152
mice (150) 150
tears - physiology (140) 140
usage (140) 140
therapy (139) 139
surgery (137) 137
follow-up studies (136) 136
adolescent (132) 132
medicine & public health (132) 132
dosage and administration (130) 130
artificial tears (128) 128
cyclosporine - administration & dosage (128) 128
glaucoma (128) 128
ocular surface disease (128) 128
sjogren's syndrome (128) 128
fluorescein (126) 126
cornea - drug effects (125) 125
cornea - pathology (125) 125
quality of life (124) 124
subcommittee (121) 121
workshop 2007 (118) 118
abridged index medicus (117) 117
expression (116) 116
medicine (112) 112
conjunctiva - pathology (108) 108
lacrimal gland (108) 108
safety (108) 108
immunosuppressive agents - administration & dosage (106) 106
retrospective studies (105) 105
dry eye syndromes - chemically induced (104) 104
cytokines (103) 103
medical research (103) 103
clinical trials (101) 101
conjunctiva (99) 99
research article (99) 99
studies (98) 98
tears - secretion (98) 98
cornea - metabolism (95) 95
cyclosporine - therapeutic use (94) 94
immunology (94) 94
article (93) 93
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2658) 2658
German (44) 44
French (24) 24
Russian (19) 19
Spanish (14) 14
Chinese (12) 12
Polish (11) 11
Japanese (10) 10
Romanian (7) 7
Korean (6) 6
Portuguese (6) 6
Turkish (3) 3
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 09/2015, Volume 213, pp. 168 - 174
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 2018, Volume 13, pp. 7251 - 7273
Introduction: Dry-eye syndrome (DES) is a general eye disease. Eye drops are the common ophthalmological medication. However, the ocular barrier makes it... 
Epigallocatechin gallate | DES | EGCG | Dry-eye syndrome | Gelatin nanoparticles | Hyaluronic acid | Anti-inflammation | CELLS | epigallocatechin gallate | dry-eye syndrome | NANOSCIENCE & NANOTECHNOLOGY | anti-inflammation | CHITOSAN NANOPARTICLES | OCULAR DRUG-DELIVERY | MODEL | hyaluronic acid | SOLID LIPID NANOPARTICLES | THERAPEUTIC-EFFICACY | IN-VIVO | DISEASE | SURFACE | PHARMACOLOGY & PHARMACY | gelatin nanoparticles | Ophthalmic Solutions - pharmacology | Nanoparticles - chemistry | Epithelial Cells - drug effects | Humans | Male | Epithelium, Corneal - pathology | Dry Eye Syndromes - pathology | Inflammation - drug therapy | Catechin - therapeutic use | Catechin - pharmacology | Gelatin - chemistry | Disease Models, Animal | Cell Survival - drug effects | Rabbits | Cytokines - metabolism | Dry Eye Syndromes - drug therapy | Ophthalmic Solutions - therapeutic use | Hyaluronic Acid - chemistry | Nanoparticles - ultrastructure | Rats | Treatment Outcome | Particle Size | Animals | Catechin - analogs & derivatives | Sus scrofa | Tears | Ethylenediaminetetraacetic acid | Nanoparticles | Catechin | Analysis | Ophthalmic drugs | Neomycin | Fluorescein | Eye diseases | Inflammation | Gene expression | Transdermal medication | Drugs | Cornea | Cytokines | Bioavailability | Retention | Molecular weight | Medicine | Engineering | Polyphenols | Laboratory animals | Biomedical engineering | Index Medicus | Dry eye syndrome (DES) | Epigallocatechin gallate (EGCG) | Hyaluronic acid (HA)
Journal Article
Journal Article
Journal Article
British Journal of Ophthalmology, ISSN 0007-1161, 10/2012, Volume 96, Issue 10, pp. 1310 - 1315
Journal Article
Journal Article